Jia Liu is a Nephrologist in Columbia, Maryland. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.

Tin Maung is a Nephrologist in Columbia, Maryland. Dr. Maung is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Acute Kidney Failure.

Ping-hsin Chen is a Nephrologist in Columbia, Maryland. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Renovascular Hypertension, Acute Kidney Failure, Acute Tubular Necrosis, and Nephrosclerosis.

Mary Pieprzak is a Nephrologist in Columbia, Maryland. Dr. Pieprzak is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.

Rao Khan is a Nephrologist in Columbia, Maryland. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, Chronic Kidney Disease, and Endoscopy.

Ajay Kumar is a Nephrologist in Columbia, Maryland. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, and Acute Tubular Necrosis.

Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover is rated as a Distinguished provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy.

Tamil Kuppusamy is a Nephrologist in Columbia, Maryland. Dr. Kuppusamy is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Vitamin D Deficiency, and Diabetic Nephropathy. Dr. Kuppusamy is currently accepting new patients.

Ritu Vyas is a Nephrologist and a Public Health and Preventive Medicine provider in Catonsville, Maryland. Dr. Vyas has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Kidney Transplant. Dr. Vyas is currently accepting new patients.

Dr. Janet L. Crane is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. Dr. Crane is the Director of the Pediatric Bone Health Program, which focuses on the care of children with rare metabolic bone diseases and osteoporosis/skeletal fragility syndromes. Dr. Crane received her bachelor’s degree in nutritional science from the University of Missouri. She completed her medical degree at the University of Maryland-Baltimore, residency in pediatrics at Children's Mercy Hospital and Clinics in Kansas City, Missouri and fellowship in pediatric endocrinology at Johns Hopkins University in 2013. Dr. Crane is a faculty member of the Center for Musculoskeletal Research. Her research is focused on bone modeling and remodeling factors that result in proper bone growth and strength. The goal of her studies is to identify diagnostic markers and therapeutic targets to enhance bone strength in children who have recurrent fractures. Dr. Crane also participates in industry sponosored clinical studies to investigate the safety and efficacy of medications for metabolic bone disease and skeletal fragility. Dr. Crane is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Osteogenesis Imperfecta, Juvenile Primary Osteoporosis, Short Stature (Growth Disorders), and Noonan Syndrome.

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Malnutrition, Exocrine Pancreatic Insufficiency, and Hormone Replacement Therapy (HRT).

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Paul Turer is a Nephrologist in Catonsville, Maryland. Dr. Turer is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Diabetic Nephropathy. Dr. Turer is currently accepting new patients.

Rudolf Pullmann is a Nephrologist in Catonsville, Maryland. Dr. Pullmann is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Tubular Necrosis, and Acute Kidney Failure. Dr. Pullmann is currently accepting new patients.

Ajay Gangalam is a Nephrologist in Catonsville, Maryland. Dr. Gangalam is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Acute Kidney Failure, Renovascular Hypertension, Nephrosclerosis, Gastrostomy, and Hip Replacement. Dr. Gangalam is currently accepting new patients.

Navneet Ahuja is a Nephrologist in Catonsville, Maryland. Dr. Ahuja is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and End-Stage Renal Disease (ESRD).

Mary Behrens is a Nephrologist in Catonsville, Maryland. Dr. Behrens is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and End-Stage Renal Disease (ESRD). Dr. Behrens is currently accepting new patients.

Robert Fuld is a Nephrologist in Baltimore, Maryland. Dr. Fuld is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Vitamin D Deficiency, and Chronic Kidney Disease. Dr. Fuld is currently accepting new patients.

Mayurkumar Gohel is a Nephrologist and a Geriatrics provider in Glen Burnie, Maryland. Dr. Gohel is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Necrosis. Dr. Gohel is currently accepting new patients.

Sarah Khan is a Nephrologist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Autosomal Dominant Hypocalcemia, Nephrosclerosis, Renovascular Hypertension, and Hypophosphatemia. Dr. Khan is currently accepting new patients.